In summary, our results demonstrate that the combination of berberine and evodiamine effectively reduces body weight and fat mass, improves lipid and glucose metabolism, and enhances insulin sensitivity in vivo, highlighting the potential of BBE as a therapeutic agent for obesity and related metabolic disorders. This evidence concerns the gene INS and Obesity.